Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Expanscience (Prexidine Assets)

1979 FOUNDED
M&A STATUS
61-70 EMPLOYEES
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A pharmaceutical drug. The asset is a drug which is used for the treatment of extra mouth infections, or care after surgery in the oral cavity.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 10, avenue de l'Arche
  • 92419 Courbevoie
  • France

Expanscience (Prexidine Assets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Expanscience (Prexidine Assets)‘s full profile, request access.

Request full access to PitchBook

Expanscience (Prexidine Assets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Expanscience (Prexidine Assets)‘s full profile, request access.

Request full access to PitchBook